NCT00042692CompletedNot Applicable
Catechol Thioethers in Parkinson's Disease
National Institute of Environmental Health Sciences (NIEHS)0 sites20 target enrollmentStarted: March 2001Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
The goal of the clinical trial aim in this project is to test whether catechol thioethers can be used as biomarkers of dopaminergic neurodegeneration.
Study Design
- Study Type
- Observational
- Observational Model
- Natural History
- Time Perspective
- Other
Eligibility Criteria
- Ages
- 0 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 1
A Study to Investigate a New Treatment in Patients With Parkinson's DiseaseParkinson DiseaseNCT03407378Tools4Patient110
Completed
Phase 2
The Use of a Mitochondrial Enhancement Treatment in Bipolar DisorderBipolar DepressionNCT00719706Mclean Hospital40
Active, not recruiting
Phase 2
Tocotrienols in Parkinson's Disease (PD)Neuro-Degenerative DiseaseParkinson DiseaseNCT04491383National Neuroscience Institute100
Completed
Phase 2
Glutathione (GSH) In The Treatment of Parkinson's DiseaseParkinson's DiseaseNCT01177319University of South Florida20
Completed
Phase 2
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIVMethamphetamine Use DisorderNCT06538285Nicky Mehtani, MD, MPH17